Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 24, 2025 • 7:01 AM ET

Date/Time Source News Release
04/15/2025 08:00 AM EDT GlobeNewswire Mural Oncology Announces Plans to Explore Strategic Alternatives
03/25/2025 06:30 AM EDT GlobeNewswire Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
03/11/2025 04:01 PM EDT GlobeNewswire Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones
02/18/2025 07:00 AM EST GlobeNewswire Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
01/09/2025 04:00 PM EST GlobeNewswire Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts
12/03/2024 04:15 PM EST GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/20/2024 04:15 PM EST GlobeNewswire Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
11/13/2024 07:00 AM EST GlobeNewswire Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
11/11/2024 07:00 AM EST GlobeNewswire Mural Oncology to Participate in Two Upcoming Investor Conferences
11/07/2024 04:15 PM EST GlobeNewswire Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Page
  • 1
  • 2

Additional News

As of April 24, 2025 • 7:01 AM ET

Date/Time Source News Release
04/16/2025 09:48 AM EDT Zacks MURA Soars as it Explores Strategic Options Post Cancer Study Failures
04/15/2025 04:55 PM EDT AllPennyStocks.com Biotech Company Sees Stock Boost Following Major Strategy Shift
04/15/2025 10:34 AM EDT 24/7 Market News Today's Top News and Trades- SKYE, KBLB, MTVA, ARBB, MURA, SNYR
04/15/2025 08:47 AM EDT 24/7 Market News Mural Oncology Pivots with $144.4M War Chest, Eyes Strategic Deals After Nemvaleukin Halt
03/28/2025 11:13 AM EDT SeekingAlpha Mural Oncology: Phase 3 Clinical Trial Setback Undermines Company's Future Prospects
03/25/2025 08:27 AM EDT SeekingAlpha Alkermes spinoff Mural plunges on plans to halt ovarian cancer trial
03/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Mural Oncology plc
03/11/2025 06:11 PM EDT SeekingAlpha Mural Oncology GAAP EPS of -$2.01 misses by $0.09
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Mural Oncology plc
11/24/2024 09:58 AM EST SeekingAlpha Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.